Evidence map›Paper›PMID 38940170›Full record

ArticleBioinformatics (Oxford, England)2024

Partial RNA design.

Frederic Runge, Jörg Franke, Daniel Fertmann, Rolf Backofen, Frank Hutter

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Artificial intelligence in bioinformatics: a survey.Briefings in bioinformatics · 2025
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Frederic RungeDepartment of Computer Science, University of Freiburg, Freiburg 79110, Germany.
Jörg FrankeDepartment of Computer Science, University of Freiburg, Freiburg 79110, Germany.
Daniel FertmannDepartment of Computer Science, University of Freiburg, Freiburg 79110, Germany.
Rolf BackofenDepartment of Computer Science, University of Freiburg, Freiburg 79110, Germany.ORCID 0000-0001-8231-3323
Frank HutterDepartment of Computer Science, University of Freiburg, Freiburg 79110, Germany.

Funding

Deutsche ForschungsgemeinschaftERC Consolidator Grant DeepLearning 2.0 101045765European Research CouncilEuropean UnionGerman Research Foundation 499552394German Research Foundation INST 39/963-1
6 · The paper itself

Abstract

motivationRNA design is a key technique to achieve new functionality in fields like synthetic biology or biotechnology. Computational tools could help to find such RNA sequences but they are often limited in their formulation of the search space.

resultsIn this work, we propose partial RNA design, a novel RNA design paradigm that addresses the limitations of current RNA design formulations. Partial RNA design describes the problem of designing RNAs from arbitrary RNA sequences and structure motifs with multiple design goals. By separating the design space from the objectives, our formulation enables the design of RNAs with variable lengths and desired properties, while still allowing precise control over sequence and structure constraints at individual positions. Based on this formulation, we introduce a new algorithm, libLEARNA, capable of efficiently solving different constraint RNA design tasks. A comprehensive analysis of various problems, including a realistic riboswitch design task, reveals the outstanding performance of libLEARNA and its robustness. AVAILABILITY AND IMPLEMENTATION: libLEARNA is open-source and publicly available at: https://github.com/automl/learna_tools.

Indexed as

AlgorithmsRNAComputational BiologyNucleic Acid ConformationRiboswitchSequence Analysis, RNASoftwareSynthetic BiologyRiboswitchRNA

Identifiers

PMID38940170
PMCPMC11256918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.